Home › LENSKART › Filing
🔔 Get instant alerts when LENSKART files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 04 Nov 2026, 17:17 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2FY27 - Revenue ₹2,845 Cr +32.5% y-y; EBITDA ₹624 Cr +46.6% y-y; PAT ₹232 Cr +106.1% y-y - India segment Q2 revenue ₹1,668 Cr +35.3% y-y; EBITDA margin 21.7% - International segment Q2 revenue ₹1,201 Cr +29.5% y-y; EBITDA margin 22.0% - Eye tests +40.4% y-y; eyewear units sold +27.1% y-y; net new stores +16.2% y-y - Trailing twelve-month EBITDA ₹2,200 Cr+; PAT ~₹800 Cr; revenue ₹10,000 Cr+ - Hyderabad manufacturing facility upcoming; strong in-house frames and lenses growth - ROCE improved by 355 bps; focus on AI and tech-driven growth
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 LENSKART — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add LENSKART to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Lenskart Solutions Limited

Important. The summary above is generated automatically from Lenskart Solutions Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.